A STEPP too far for FLEX? - Authors' reply


Autoria(s): Pirker, Robert; Störkel, Stephan; Von Heydebreck, Anya; Celik, Ilhan; O'Byrne, Kenneth J.
Data(s)

2012

Identificador

http://eprints.qut.edu.au/65350/

Publicador

The Lancet Publishing Group

Relação

DOI:10.1016/S1470-2045(12)70057-8

Pirker, Robert, Störkel, Stephan, Von Heydebreck, Anya, Celik, Ilhan, & O'Byrne, Kenneth J. (2012) A STEPP too far for FLEX? - Authors' reply. The Lancet Oncology, 13(2).

Direitos

Copyright 2012 The Lancet Publishing Group

Fonte

School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation

Palavras-Chave #cetuximab #epidermal growth factor receptor #advanced cancer #clinical assessment tool #drug efficacy #histopathology #letter #lung non small cell cancer #outcome assessment #priority journal #protein expression #squamous cell carcinoma #subpopulation treatment effect pattern plot #treatment response
Tipo

Journal Article